Drug candidates from traditional chinese medicines.

  title={Drug candidates from traditional chinese medicines.},
  author={Jing-Fang Wang and Dongqing Wei and K. Chou},
  journal={Current topics in medicinal chemistry},
  volume={8 18},
Good progress has been made to modernize traditional Chinese medicines by obtaining active components from natural herbs. In this review, some recent works on procuring active components and modernizing traditional Chinese medicines will be covered. In addition, some recent works on drug design using modern drug design tools have been described. With some well defined targets, the traditional Chinese medicine databases have been screened so as to identify those compounds for which the potential… Expand
Screening for the bioactive constituents of traditional Chinese medicines—progress and challenges
This review provides a toolbox of the experimental screening methods and models that have been applied to discover new lead compounds and drugs from TCMs, assisting readers in the rapid retrieval of useful information and providing reference values for selecting appropriate screening tools for different research. Expand
New Perspectives on Chinese Herbal Medicine (Zhong-Yao) Research and Development
This narrative review illustrates various approaches to the research and drug discovery in Chinese herbal medicine, focusing on Chinese traditional drugs, and is conducive to the development of other traditional remedies and innovative drug discovery. Expand
The screening toolbox of bioactive substances from natural products: a review.
This review provides a toolbox of experimental screening models that have been used to discover new drug candidates from natural products and discusses ways of improving model systems, as well as future directions. Expand
Potential agents for cancer and obesity treatment with herbal medicines from the green garden
This review will address the current advances in using traditional herbal plants, including the pharmacological effects and the challenges faced during the development of new drugs, as well as the safety issues associated with toxicity and the effectiveness of the herbs in specific diseases. Expand
Material Basis of Chinese Herbal Formulas Explored by Combining Pharmacokinetics with Network Pharmacology
It is concluded that a sensitive, reliable, and suitable LC-MS/MS method for both the composition and pharmacokinetic study of BZ has been established and the combination of PK with network pharmacology might be a potent method for exploring the material basis of TCM formulas. Expand
A Novel Methodology for Multicomponent Drug Design and Its Application in Optimizing the Combination of Active Components from Chinese Medicinal Formula Shenmai
A new method based upon lattice experimental design and multivariate regression was applied to model the quantitative composition‐activity relationship (QCAR) in this study, and multi‐objective optimization was achieved by Derringer function using extensive search algorithm. Expand
Progress on the screening and analysis of bioactive compounds in traditional chinese medicines by biological fingerprinting analysis.
Recent progress in the development of biological fingerprinting strategies for screening and analyzing of bioactive compounds in TCMs using molecular recognition, metabolism and omics tools are summarized. Expand
Computational investigation of the Anti-HIV activity of Chinese medicinal formula Three-Huang Powder
To understand how the inhibitors work and therefore design more potent and specific inhibitors, molecular modeling techniques are used to investigate the binding modes of these inhibitors and demonstrate that Baicalein binds to the active site region of the HIV-1 integrase. Expand
Analysis of Pogostemon cablin from pharmaceutical research to market performances
Various components extracted from this plant as well as the biological activities derived from those chemical compositions are reviewed, highlighting the therapeutic effects of P. cablin, such as antiviral activities, antioxidation effect, antiinflammatory, analgesic activities, and intestinal barrier function protection. Expand
An Overview of the Evidence and Mechanisms of Herb–Drug Interactions
The potential for HDI should always be assessed in the non-clinical safety assessment phase of drug development process and an increased level of awareness of HDI is necessary among health professionals and drug discovery scientists. Expand